Featured Insights
December 17, 2024
D. Boral Capital: Philanthropic Endeavors Continue with Donations to Keep a Child Alive and Project Rosseau
March 27, 2025
D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering
March 26, 2025
D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
March 4, 2025
D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement
February 28, 2025
D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering
February 21, 2025
D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering
